tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market

Royalty Pharma (RPRX) Technical Analysis

Compare
1,247 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is 1.06, suggesting Royalty Pharma PLC is a Buy.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 31.65, while Royalty Pharma PLC’s (RPRX) share price is $33.33, making it a Buy.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 29.82, while Royalty Pharma PLC’s (RPRX) share price is $33.33, making it a Buy.

Royalty Pharma (RPRX) Pivot Points

Feb 21, 2025, 11:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
31.67
31.99
32.29
32.60
32.90
33.22
33.52
Fibonacci
31.99
32.22
32.37
32.60
32.84
32.98
33.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Feb 21, 2025, 11:22 AM
Period
Simple
Exponential
MA5
32.72Buy
32.76Buy
MA10
32.30Buy
32.39Buy
MA20
31.88Buy
31.65Buy
MA50
28.77Buy
29.82Buy
MA100
27.83Buy
28.66Buy
MA200
27.47Buy
28.14Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 32.39, while Royalty Pharma PLC’s (RPRX) share price is $33.33, making it a Buy.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 28.66, while Royalty Pharma PLC’s (RPRX) share price is $33.33, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $33.33 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 28.77, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $33.33 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 27.83, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $33.33 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 27.47, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Feb 21, 2025, 11:22 AM
Name
Value
Implied Action
RSI (14)
77.68
Sell
STOCH (9,6)
87.77
Sell
STOCHRSI (14)
89.02
Sell
MACD (12,26)
1.06
Buy
ADX (14)
49.97
Neutral
Williams %R
-13.53
Sell
CCI (14)
170.36
Sell
ATR (14)
0.71
-
Ultimate Oscillator
66.25
Neutral
ROC
5.51
Buy
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 77.68, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 49.97, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is 170.36, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is 5.51, creating a Buy signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Buy.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 77.68, which suggests RPRX is a Sell.
      What is RPRX’s MACD?
      RPRX’s MACD is 1.06, which suggests RPRX is a Buy.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 32.72, which suggests RPRX is a Buy.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 31.88, which suggests RPRX is a Buy.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 28.77, which suggests RPRX is a Buy.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 27.47, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -13.53, which suggests RPRX is a Sell.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is 170.36, which suggests RPRX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis